Skip to main content
Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
4.260
+0.090 (2.16%)
At close: Dec 5, 2025, 4:00 PM EST
4.250
-0.010 (-0.23%)
After-hours: Dec 5, 2025, 5:55 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2021 FY 2019 FY 2018 2014 - 2019
Period Ending
 Dec '24 Dec '23 Dec '21 Dec '19 Dec '18 2014 - 2019
Gene Therapeutics
1.00M
Log In
Log In
Log In
Log In
Upgrade
Gene Therapeutics Growth
-72.22%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2021 FY 2019 FY 2018 2014 - 2019
Period Ending
 Dec '24 Dec '23 Dec '21 Dec '19 Dec '18 2014 - 2019
United States
1.00M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-72.22%
Log In
Log In
Log In
Log In
Upgrade